BFA
MRNA icon

Beaumont Financial Advisors’s Moderna MRNA Stock Holding History

Beaumont Financial Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-10,439
Closed -$72.8K – 343
2023
Q2 		$72.8K Buy
10,439
+8,921
+588% +$1.19M 0.01% 339
2023
Q1 		$233K Sell
1,518
-64
-4% -$10.6K 0.02% 284
2022
Q4 		$284K Buy
+1,582
New +$259K 0.03% 261
2022
Q3 		– Sell
-1,730
Closed -$247K – 318
2022
Q2 		$247K Sell
1,730
-123
-7% -$17.6K 0.02% 270
2022
Q1 		$319K Buy
1,853
+2
+0.1% +$337 0.02% 272
2021
Q4 		$470K Sell
1,851
-10
-0.5% -$2.92K 0.03% 220
2021
Q3 		$716K Sell
1,861
-268
-13% -$98.8K 0.06% 171
2021
Q2 		$500K Buy
+2,129
New +$380K 0.04% 209

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Beaumont Financial Advisors's MRNA Position: Q3 2023 in Review

Beaumont Financial Advisors sold out of Moderna (MRNA) in Q3 2023, closing a stake of 10,439 shares — an estimated $72.8K sold.

Beaumont Financial Advisors first reported a position in MRNA in Q2 2021 and held it in 8 quarters. The position peaked at $716K in Q3 2021. 889 funds tracked by Wall St. Rank hold MRNA as of Q3 2023.

  • Beaumont Financial Advisors reported no remaining Moderna position as of Q3 2023 after selling out during the quarter.
  • Beaumont Financial Advisors sold 10,439 Moderna shares in Q3 2023, an estimated $72.8K.
  • Beaumont Financial Advisors first reported a position in Moderna in Q2 2021 and held it in 8 quarters.
  • Beaumont Financial Advisors's Moderna position peaked at $716K in Q3 2021.
  • 889 funds tracked by Wall St. Rank held Moderna as of Q3 2023.

Based on Beaumont Financial Advisors's 13F filing for Q3 2023, filed 1 Nov 2023.